Citigroup’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-35,000
Closed -$658K 5722
2024
Q1
$658K Buy
35,000
+7,500
+27% +$129K ﹤0.01% 3369
2023
Q4
$397K Sell
27,500
-29,900
-52% -$407K ﹤0.01% 3568
2023
Q3
$996K Buy
+57,400
New +$1.2M ﹤0.01% 2516

Other funds holding OGN

Citigroup's OGN Position: Q1 2026 in Review

Citigroup increased its Organon & Co (OGN) stake by 18% in Q1 2026, buying an estimated $683K and bringing the position to 596,772 shares worth $3.57M. The position accounts for ﹤0.01% of the portfolio, ranked #2233.

Citigroup first reported a position in OGN in Q2 2021 and has held it in 20 quarters since. The position peaked at $18.2M in Q2 2021. 603 funds tracked by Wall St. Rank hold OGN as of Q1 2026.

  • Citigroup held 596,772 shares of Organon & Co worth $3.57M as of Q1 2026.
  • Citigroup bought 90,721 Organon & Co shares in Q1 2026, an estimated $683K.
  • Organon & Co made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #2233 holding.
  • Citigroup first reported a position in Organon & Co in Q2 2021 and has held it in 20 quarters since.
  • Citigroup's Organon & Co position peaked at $18.2M in Q2 2021.
  • 603 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.